Role of chemoradiotherapy in intermediate prognosis nasopharyngeal carcinoma

Concurrent chemoradiotherapy appeared to improve the 5-year RFS rate for patients with T2N1M0 NPC. Large prospective, randomized clinical studies are needed to confirm its therapeutic gain.